Core Scientific Inc New
CORZR News Today: Stay Updated with the Latest Core Scientific Inc New News in Real Time
Find CORZR news now at Meyka AI. Stay informed with the latest Core Scientific Inc New stocks updates, including price news, market analysis, and expert insights.

Q4 results hit Verano Holdings (VRNO.NE NEO) on 26 Feb 2026: margin outlook is the key
VRNO.NE stock trades at C$1.56 after Q4 results on 26 Feb 2026. Read our earnings spotlight, metrics, Meyka AI grade and forecast for VRNO.NE stock

Deividas Skebas Jailed: February 26 β UK Safety Spend in Focus
Deividas Skebas jailed on 26 February sharpens UK crime sentencing debate. We assess public safety spending shifts and the outlook for security contractors UK.

WBD Warner Bros. Discovery NASDAQ 26 Feb 2026: Q4 earnings before $31 bid
WBD stock preview: Warner Bros. Discovery reports Q4 on 26 Feb 2026 as bidders raise offer. Key metrics, Meyka forecast and merger risk

Earnings due: VK.PA Vallourec S.A. (EURONEXT) after-hours Feb 2026, margins key
VK.PA stock pre-earnings: Vallourec reports 27 Feb 2026 after-hours, margins and cash flow will drive reaction

^GSPC Today February 26: SOTU Tariff, Immigration Risks in Focus
How long was Trumpβs State of matters less than policy signals. We break down SOTU market impact, Trump tariff policy, and immigration enforcement risk for Canadians, with ^GSPC levels, technicals, ΠΈs

BTCUSD Today February 26: Jane Street 10am Sells, Terra Suit Stokes Risk
Jane Streetβs alleged 10 a.m. ET selling and a fresh Terra lawsuit are stirring Bitcoin price today. What this could mean for Canadian investors, MicroStrategy MSTR, and BlackRock IBIT.

MARA (Marathon Digital NASDAQ) earnings due 26 Feb 2026: watch BTC sensitivity
MARA stock earnings spotlight: Q4 results, valuation, Meyka forecast and price targets for NASDAQ Marathon Digital

QAN.AX Stock Today: February 27 β Sydney-Las Vegas Flights Book Now
Qantas stock in focus as Qantas opens bookings for Sydney to Las Vegas flights. See QAN.AX share price, catalysts, key levels, and what matters for Hong Kong investors today.

CHF129.60 Novartis (NOVN.SW, SIX) intraday 26 Feb 2026: Meyka sees 18.35% upside
Intraday NOVN.SW stock update: Novartis at CHF129.60 on SIX, volume 3.67M, Meyka forecast shows 18.35% five-year upside